Minerva Neurosciences, Inc. (NERV)
USD 2.19
(-5.6%)
USD 2.19
(-5.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 41.17 Million | - | - |
| Cost of Revenue | 30.98 Thousand | 8513.00 | 101.78 Thousand | - | 161.5 Thousand | 17.46 Thousand |
| Gross Profit | -30.98 Thousand | -8513.00 | -101.78 Thousand | 41.17 Million | -161.5 Thousand | -17.46 Thousand |
| Operating Expenses | 23.08 Million | 25.23 Million | 45.36 Million | 39.32 Million | 75.86 Million | 51.72 Million |
| Selling, General and Administrative Expenses | 10.38 Million | 10.58 Million | 13.32 Million | 17.28 Million | 17.74 Million | 16.84 Million |
| Research and Development Expenses | 12.7 Million | 14.64 Million | 32.03 Million | 22.03 Million | 58.12 Million | 34.88 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 23.11 Million | 25.23 Million | 45.36 Million | 39.32 Million | 75.86 Million | 51.72 Million |
| Operating Income | -23.11 Million | -25.23 Million | -45.36 Million | 1.84 Million | -75.86 Million | -51.72 Million |
| Interest Expense | 8.28 Million | 7.4 Million | 6.32 Million | - | - | 110.44 Thousand |
| Income Tax Expense | -2.00 | 6.87 Million | -1.8 Million | -94.02 Thousand | -2.25 Million | 1.66 Million |
| Earnings before Tax | -30 Million | -32.1 Million | -51.7 Million | 1.94 Million | -74.43 Million | -50.17 Million |
| Net Income | -30 Million | -38.98 Million | -49.9 Million | 1.94 Million | -72.18 Million | -50.17 Million |
| Earnings Per Share Basic | -4.61 | -7.30 | -9.35 | 0.38 | -14.80 | -10.35 |
| Earnings Per Share Diluted | -4.61 | -7.30 | -9.35 | 0.38 | -14.80 | -10.35 |
| Weighted Average Shares Outstanding | 6.5 Million | 5.34 Million | 5.34 Million | 5.1 Million | 4.87 Million | 4.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.5 Million | 5.34 Million | 5.34 Million | 5.11 Million | 4.87 Million | 4.84 Million |
| Gross Margin | - | - | - | 1.00 | - | - |
| EBIT Margin | - | - | - | 0.05 | - | - |
| Profit Margin | - | - | - | 0.05 | - | - |
| EBITDA | -21.69 Million | -24.69 Million | -51.6 Million | 1.92 Million | -74.27 Million | -50.04 Million |
| Earnings Before Tax Margin | - | - | - | 0.04 | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 7746.00 | 7745.00 | 7746.00 | 30.98 Thousand | 7745.00 |
| Gross Profit | - | -7746.00 | -7745.00 | -7746.00 | -30.98 Thousand | -7745.00 |
| Operating Expenses | 4366.7 Billion | 6.26 Million | 6.67 Million | 7.16 Million | 23.08 Million | 6.07 Million |
| Selling, General and Administrative Expenses | 2478.78 Billion | 2.4 Million | 2.5 Million | 2.44 Million | - | 2.63 Million |
| Research and Development Expenses | 1887.91 Billion | 3.86 Million | 4.16 Million | 4.72 Million | - | 3.44 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4366.7 Billion | 6.27 Million | 6.68 Million | 7.17 Million | 23.11 Million | 6.07 Million |
| Operating Income | -4366.7 Billion | -6.27 Million | -6.68 Million | -7.17 Million | -23.11 Million | -6.07 Million |
| Interest Expense | - | 2.31 Million | 2.25 Million | 2.19 Million | 8.28 Million | -2.08 Million |
| Income Tax Expense | - | 4.00 | -5.00 | -5.62 Million | -2.00 | -7745.00 |
| Earnings before Tax | 22513.2 Billion | -8.23 Million | -8.56 Million | -9.02 Million | -30 Million | -7.82 Million |
| Net Income | 22513.2 Billion | -8.23 Million | -8.56 Million | -9.02 Million | -30 Million | -7.82 Million |
| Earnings Per Share Basic | 2.97 Million | -1.09 | -1.13 | -1.19 | - | -1.03 |
| Earnings Per Share Diluted | 2.97 Million | -1.09 | -1.13 | -1.19 | - | -1.03 |
| Weighted Average Shares Outstanding | 7.56 Million | 7.56 Million | 7.56 Million | 7.56 Million | 6.5 Million | 7.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.56 Million | 7.56 Million | 7.56 Million | 7.56 Million | 6.5 Million | 7.56 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4366.7 Billion | -6.26 Million | -6.67 Million | -7.16 Million | - | -6.07 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
GBIO
GPTHEALTH
AGRO3
KOCMT
LOVABLE
UNITECH